GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.2712 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, NR3C1, NR3C2, PGR, PPARA, PPARG, RORC, SRC |
11.0123 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.5951 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALOX15, ALPL, AR, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, ESRRA, FABP3, FABP4, FLT3, GPER1, GRIK5, GRM5, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, KDR, MMP2, NR3C1, PPARA, PPARG, RORC, SRC, TYR |
10.4072 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, AR, AXL, BCL2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FABP3, GPER1, GRIK5, GRM5, HSD17B2, HSP90AB1, IGF1R, MMP2, MMP9, NR3C1, PPARA, PPARG, RORC, SRC, TYR |
10.3813 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, NR3C1, NR3C2, PGR, PPARA, PPARG, RORC, SRC |
9.86297 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, NR3C1, PGR, PIM1, PPARA, PPARG, RORC, SRC |
9.64811 |
[BP] GO:0042221 |
response to chemical
|
ABCG2, AKR1B1, ALOX15, ALPL, AR, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, ESRRA, FABP3, FABP4, FLT3, GPER1, GRIK5, GRM5, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, KDR, MMP2, MMP9, NR3C1, PPARA, PPARG, RORC, SRC, TYR |
9.4132 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
9.38418 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AR, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, GPER1, HSD17B2, NR3C1, PPARG, RORC, SRC, TYR |
9.37754 |
[BP] GO:0065008 |
regulation of biological quality
|
ABCG2, ACHE, ADORA1, ADRB1, AKR1B1, ALOX15, AR, AURKB, AXL, BCL2, CA12, CA2, CA7, CACNA1C, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, FABP3, FABP4, FLT3, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HCAR2, HSD11B1, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, KDR, MET, PPARA, PPARG, SLC1A1, SRC, XDH |
9.13182 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, ERBB2, ESR1, FABP3, FABP4, FUT7, HSD11B1, HSD17B1, HSD17B2, MET, PPARA, PPARG |
8.56541 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FLT3, GPER1, HSP90AB1, NR3C1, PPARG, RORC, SRC, TYR |
8.40157 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AR, AXL, BCL2, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ERBB2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, HSP90AB1, KDR, PPARA, PPARG, SRC, TYR |
7.90395 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ERBB2, ESR1, ESRRA, FABP3, FLT3, GPER1, GRM5, IGF1R, MMP2, NR3C1, PPARA, PPARG, SRC |
7.8219 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, ALPL, AR, AXL, BCL2, CYP1A1, CYP1B1, EGFR, ERBB2, ESR1, FABP4, FLT3, GPER1, GRIK5, GRM5, HSP90AB1, IGF1R, KDR, MMP2, NR3C1, PPARG, RORC, SRC |
7.70723 |
[BP] GO:0044281 |
small molecule metabolic process
|
ABCG2, AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, FUT7, PIM1, PPARA, PPARG, TYR, XDH |
7.65779 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, NR3C2, PGR, PPARA, PPARG, RORC |
7.61036 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, ALPL, AR, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, FABP4, FLT3, GPER1, GRIK5, GRM5, HSP90AB1, IGF1R, KDR, MMP2, MMP9, NR3C1, PPARG, RORC, SRC |
7.5312 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, GPER1, NR3C1, PPARA, PPARG, SRC |
7.30484 |
[BP] GO:0042592 |
homeostatic process
|
ABCG2, ADORA1, ADRB1, AKR1B1, AXL, BCL2, CA12, CA2, CA7, CACNA1C, EGFR, ESR1, FABP3, FABP4, FLT3, GPER1, GRIK5, GRM1, GRM5, HSP90AA1, HSP90AB1, MET, PPARG, SRC |
6.78574 |
[BP] GO:0007215 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
6.63816 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRB1, AKR1B1, ALOX15, AR, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GPER1, GRIK5, GRM1, GRM5, HCAR2, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, NR3C1, PGR, PIM1, PPARA, PPARG, PTPN1, RORC, SRC, XDH |
6.62372 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, NR3C2, PGR, PPARA, PPARG, RORC |
6.54816 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA, PPARG, SLC1A1 |
6.32991 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, AR, CYP1A1, CYP1B1, EGFR, ESR1, FLT3, GPER1, HSP90AB1, NR3C1, PPARG, RORC, SRC |
6.24884 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRB1, AKR1B1, ALOX15, AR, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GPER1, GRIK5, GRM1, GRM5, HCAR2, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, NR3C1, PGR, PIM1, PPARA, PPARG, PTPN1, RORC, SLC1A1, SRC, XDH |
6.138 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRB1, AKR1B1, AR, AXL, BCL2, CA1, CA2, CACNA1C, CSNK2A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, PPARG, PTPN1, RORC, SRC |
6.0375 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GPER1, GRIK5, HCAR2, HSP90AB1, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PPARG, PTPN1, SRC, XDH |
6.02904 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRB1, AKR1B1, ALOX15, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, FLT3, GPER1, GRM1, HCAR2, HSP90AB1, KDR, MET, MMP9, PTPN1, SRC, XDH |
5.99949 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GPER1, GRIK5, HCAR2, HSP90AB1, IGF1R, KDR, MET, MMP9, PIM1, PPARG, PTPN1, SRC, XDH |
5.97809 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRB1, AKR1B1, ALOX15, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, FLT3, GPER1, GRM1, HCAR2, HSP90AB1, KDR, MET, MMP9, PTPN1, SRC, XDH |
5.97809 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRB1, AKR1B1, ALOX15, AR, AURKB, AXL, BCL2, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, FLT3, GPER1, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSP90AB1, IGF1R, KDR, MET, MMP9, PPARG, PTPN1, SRC, XDH |
5.92975 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, ESR1, HSD11B1, HSD17B1, HSD17B2 |
5.83798 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRB1, AKR1B1, ALOX15, AR, AURKB, AXL, BCL2, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, FLT3, GPER1, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSP90AB1, IGF1R, KDR, MET, MMP9, PPARG, PTPN1, SRC, XDH |
5.80748 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALOX15, ALPL, AR, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, FABP4, FLT3, GPER1, GRIK5, GRM1, GRM5, HSP90AB1, IGF1R, KDR, MMP2, MMP9, NR3C1, PPARG, PTPN1, RORC, SRC |
5.60821 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRB1, ALOX15, AR, BCL2, CDC25B, EGFR, ERBB2, ESRRB, FABP3, FABP4, FLT3, GPER1, GRM1, GRM3, GRM5, GRM8, HSP90AB1, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
5.59268 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRB1, ALOX15, AR, BCL2, CDC25B, EGFR, ERBB2, ESRRB, FABP3, FLT3, GPER1, GRM1, GRM5, HSP90AB1, KDR, MMP9, PTPN1, SRC, XDH |
5.57415 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRB1, ALOX15, AR, BCL2, CDC25B, EGFR, ERBB2, ESRRB, FABP3, FLT3, GPER1, GRM1, GRM5, HSP90AB1, KDR, MMP9, PTPN1, SRC, XDH |
5.57415 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRB1, ALOX15, AR, BCL2, CDC25B, EGFR, ERBB2, ESRRB, FABP3, FABP4, FLT3, GPER1, GRM1, GRM3, GRM5, GRM8, HSP90AB1, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
5.5498 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, AR, BCL2, CDC25B, CSNK2A1, CYP1B1, EGFR, ERBB2, ESR1, ESRRA, FABP3, FLT3, GPER1, IGF1R, KDR, MMP2, MMP9, PGR, PIM1, PPARG, SRC, XDH |
5.45062 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GPER1, GRIK5, HCAR2, HSP90AB1, IGF1R, KDR, MMP9, PIM1, PPARG, PTPN1, SRC, XDH |
5.42881 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CACNA1C, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, GPER1, HCAR2, HSD11B1, HSD17B1, HSD17B2 |
5.4168 |
[BP] GO:0008152 |
metabolic process
|
ABCG2, ACHE, ADORA1, ADRB1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, PPARG, PTPN1, RORC, SRC, TYR, XDH |
5.30315 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.28081 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRB1, ALOX15, AR, AURKB, BCL2, CDC25B, CSNK2A1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, GRM1, GRM5, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP9, NR3C1, PGR, PPARA, PPARG, PTPN1, RORC, SRC, XDH |
5.17437 |
[BP] GO:0030518 |
intracellular steroid hormone receptor signaling pathway
|
AR, ESR1, ESR2, GPER1, NR3C1, PGR, SRC |
5.12474 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA, PPARG, SLC1A1 |
5.09859 |
[BP] GO:0007196 |
None
|
GRM1, GRM3, GRM5, GRM8 |
5.0969 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, CA2, CA7, EGFR, GPER1, GRIK5, GRM1, GRM3, GRM5, GRM8 |
5.0969 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, CA2, CA7, EGFR, GPER1, GRIK5, GRM1, GRM3, GRM5, GRM8 |
5.0969 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, KDR, MMP9, SRC |
5.06066 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX15, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, ERBB2, FABP3, FABP4, FUT7, MET, PPARA, PPARG |
5.05565 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AR, AXL, CYP1B1, EGFR, ESR1, GPER1, GRIK5, GRM5, IGF1R, MMP2, MMP9, NR3C1, PPARG, RORC, SRC |
5.00927 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRB1, AKR1B1, ALOX15, AR, AXL, BCL2, CYP1B1, EGFR, ERBB2, FLT3, GPER1, GRM1, KDR, MET, PTPN1, SRC, XDH |
4.98456 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ALOX15, AR, BCL2, CDC25B, EGFR, ERBB2, ESRRB, FLT3, GPER1, GRM1, GRM5, HSP90AB1, KDR, MMP9, PTPN1, SRC, XDH |
4.90779 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD17B1, HSD17B2 |
4.89057 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, ERBB2, FLT3, HSP90AA1, IGF1R, KDR, MET, SRC |
4.87824 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALOX15, ALPL, AR, AXL, BCL2, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, HSP90AB1, KDR, MMP9, PGR, PIM1, PPARA, PPARG, RORC, SRC, TYR |
4.87824 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRB1, ALOX15, AR, AURKB, BCL2, CDC25B, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GPER1, GRM1, GRM5, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP9, NR3C1, PGR, PPARA, PPARG, PTPN1, RORC, SRC, XDH |
4.8764 |
[BP] GO:0050896 |
response to stimulus
|
ABCG2, ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, ALOX15, ALPL, AR, AURKB, AXL, BCL2, CA2, CA6, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, ESRRA, FABP3, FABP4, FLT3, GPER1, GRIK5, GRM1, GRM5, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, KDR, MMP2, MMP9, NR3C1, PPARA, PPARG, PTPN1, RORC, SRC, TYR |
4.85058 |
[BP] GO:0044237 |
cellular metabolic process
|
ABCG2, ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP1, MMP2, NR3C1, NR3C2, PGR, PIM1, PPARA, PPARG, PTPN1, RORC, SRC, TYR, XDH |
4.85058 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, ERBB2, FLT3, HSP90AA1, IGF1R, KDR, MET, SRC |
4.83961 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD11B1, HSD17B1, HSD17B2, PPARG, TYR, XDH |
4.81645 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
4.78542 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, PIM1, SRC |
4.72683 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, ADRB1, AKR1B1, ALOX15, ALPL, AR, AURKB, AXL, BCL2, CA2, CA9, CACNA1C, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, HSD11B1, HSD17B2, HSP90AB1, KDR, MET, MMP2, MMP9, PGR, PIM1, PPARA, PPARG, RORC, SRC, TYR |
4.71433 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AR, AXL, BCL2, CDC25B, CYP19A1, EGFR, ESR1, ESRRB, HSD17B2, HSP90AB1, PGR, PPARG, SRC |
4.69503 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRB1, ALOX15, AR, AURKB, BCL2, CDC25B, CSNK2A1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GPER1, GRM1, GRM5, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP9, NR3C1, PGR, PPARA, PPARG, PTPN1, RORC, SRC, XDH |
4.69006 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
4.60769 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, EGFR, GRM1, GRM3, GRM5, GRM8 |
4.58084 |
[BP] GO:0048878 |
chemical homeostasis
|
ABCG2, AKR1B1, BCL2, CA12, CA2, CA7, CACNA1C, EGFR, ESR1, FABP3, FABP4, GPER1, GRIK5, GRM1, GRM5, MET, PPARG |
4.52449 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ALOX15, AR, BCL2, CDC25B, EGFR, ERBB2, FLT3, GPER1, GRM1, GRM5, HSP90AB1, KDR, MMP9, PTPN1, SRC, XDH |
4.51554 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, EGFR, HSP90AB1, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SRC |
4.48712 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, EGFR, ESR1, PGR, PPARA, PPARG, RORC, SRC |
4.43087 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
4.42745 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, AR, BCL2, CA2, EGFR, FLT3, GPER1, NR3C1, SRC |
4.37042 |
[BP] GO:0007216 |
None
|
GRM1, GRM3, GRM5, GRM8 |
4.35591 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ALOX15, AR, AURKB, BCL2, CDC25B, CSNK2A1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, GRM1, GRM5, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP9, NR3C1, PGR, PPARA, PPARG, PTPN1, RORC, SRC, XDH |
4.34244 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.33416 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.33416 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, EGFR, HSP90AB1, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SRC |
4.3068 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PPARA, PPARG |
4.29714 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ALOX15, AR, BCL2, CDC25B, EGFR, ERBB2, ESRRB, FABP4, FLT3, GPER1, GRM1, GRM5, HSP90AB1, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
4.29714 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRB1, AKR1B1, ALOX15, AR, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ERBB2, FLT3, GPER1, GRM1, HSP90AB1, KDR, MET, MMP9, PTPN1, SRC, XDH |
4.25298 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRB1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AR, AXL, BCL2, CACNA1C, CYP19A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRB, FABP4, GPER1, GRM1, GRM5, GRM8, HSD17B2, IGF1R, MET, MMP1, MMP2, MMP9, PIM1, PPARA, RORC, SRC, TYR |
4.2439 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRB1, AKR1B1, ALOX15, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ERBB2, ESR1, FLT3, GPER1, GRM1, IGF1R, KDR, MET, MMP9, PTPN1, SRC, XDH |
4.18702 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ALOX15, AR, AXL, BCL2, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, GPER1, GRIK5, GRM5, HCAR2, HSP90AB1, IGF1R, KDR, MET, MMP9, PPARA, PPARG, PTPN1, SRC |
4.08937 |
[BP] GO:0071383 |
None
|
AR, EGFR, FLT3, GPER1, NR3C1, SRC |
4.06377 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, AXL, BCL2, CA1, CSNK2A1, EGFR, ERBB2, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
4.04569 |
[BP] GO:1901654 |
None
|
AKR1B1, AR, CA9, CSNK2A1, EGFR, NR3C1, PPARG, SRC |
4.03041 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, BCL2, CYP1A1, EGFR, ERBB2, PPARA |
4.01534 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRB1, AKR1B1, ALOX15, AR, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ERBB2, ESRRA, FABP4, FLT3, GPER1, GRM1, HSP90AA1, HSP90AB1, KDR, MET, MMP2, MMP9, PTPN1, SRC, XDH |
4.00678 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, ERBB2, FLT3, HSP90AA1, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
3.9965 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, ADRB1, AR, AURKB, BCL2, CDC25B, EGFR, ERBB2, ESR1, ESR2, FLT3, GPER1, GRM1, GRM5, HSP90AA1, HSP90AB1, MET, MMP9, PPARG, PTPN1, SRC, XDH |
3.91898 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ALOX15, AR, EGFR, ERBB2, FLT3, GPER1, GRM1, KDR, PTPN1, SRC, XDH |
3.89787 |
[BP] GO:1901655 |
None
|
AKR1B1, AR, EGFR, NR3C1, PPARG, SRC |
3.8763 |
[BP] GO:0042493 |
response to drug
|
ABCG2, AKR1B1, AXL, BCL2, CA9, CYP1A1, CYP1B1, EGFR, FABP3, HSP90AB1, KDR, NR3C1, PPARG, SRC |
3.7669 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, EGFR, HSP90AB1, IGF1R, KDR, MMP9, PIM1, PTPN1, SRC |
3.73857 |
[BP] GO:0048608 |
reproductive structure development
|
AR, AXL, BCL2, CYP19A1, ESR1, HSD17B2, HSP90AB1, PPARG, SRC |
3.72789 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
ADRB1, AR, AURKB, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, GPER1, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, NR3C1, PGR, PPARA, PPARG, RORC, SRC |
3.69534 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ALOX15, AR, BCL2, CDC25B, EGFR, ERBB2, FABP4, FLT3, GPER1, GRM1, GRM5, HSP90AB1, IGF1R, KDR, MMP9, PTPN1, SRC, XDH |
3.67935 |
[BP] GO:0071396 |
cellular response to lipid
|
AR, AXL, EGFR, ESR1, FLT3, GPER1, NR3C1, PPARG, RORC, SRC |
3.67454 |
[BP] GO:0051972 |
regulation of telomerase activity
|
AURKB, HSP90AA1, HSP90AB1, PPARG, SRC |
3.67454 |
[BP] GO:0007154 |
None
|
ADORA1, ADRB1, AR, AXL, BCL2, CACNA1C, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, PGR, PPARG, SLC1A1 |
3.67366 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRB1, AR, AURKB, BCL2, CDC25B, CSNK2A1, EGFR, ERBB2, ESR1, FABP4, FLT3, GPER1, GRM1, GRM3, GRM5, HSP90AA1, HSP90AB1, IGF1R, MMP9, PPARG, PTPN1, SRC, XDH |
3.63524 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AR, AURKB, BCL2, CYP1A1, EGFR, ERBB2, ESR1, FLT3, MET, PIM1, SRC, TYR |
3.61166 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, FABP3, FLT3, GPER1, HCAR2, PPARA, PPARG, RORC, SRC |
3.61166 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, CACNA1C, GPER1, KDR, SRC |
3.60995 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, ADRB1, AKR1B1, AURKB, BCL2, CA2, CYP1A1, EGFR, GRM1, HSP90AA1, HSP90AB1, MMP2, PPARA, PPARG, SRC, TYR |
3.60957 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, AR, BCL2, CDC25B, CSNK2A1, EGFR, ERBB2, ESR1, FLT3, GPER1, IGF1R, KDR, MMP2, MMP9, PIM1 |
3.59254 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, BCL2, CACNA1C, CYP19A1, CYP1B1, EGFR, ERBB2, GPER1, IGF1R, KDR, MET, MMP9, PPARG, SRC |
3.54512 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.54512 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.54512 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.50341 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
ADRB1, AR, AURKB, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, GPER1, HSP90AA1, HSP90AB1, IGF1R, MET, NR3C1, PGR, PPARA, PPARG, PTPN1, RORC, SRC |
3.48383 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, BCL2, CA2, CA7, CACNA1C, EGFR, GPER1, HCAR2, KDR, SRC |
3.44171 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, FABP3, GRIA2, GRIA4, GRIK5, PPARA, PPARG, SLC1A1 |
3.44171 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, AR, EGFR, ERBB2, ESR1, FLT3, GPER1, GRM5, IGF1R, MMP2, NR3C1, PPARG, SRC |
3.44171 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, EGFR, FLT3, GPER1, NR3C1, SRC |
3.44171 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
3.44171 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
3.43039 |
[BP] GO:0007188 |
None
|
ADORA1, ADRB1, GPER1, GRM1, GRM3, GRM5, GRM8 |
3.43035 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ALOX15, AR, BCL2, CDC25B, CSNK2A1, EGFR, ERBB2, ESR1, FLT3, GPER1, GRM1, GRM5, HSP90AB1, KDR, MMP9, PPARG, PTPN1, SRC, XDH |
3.32068 |
[BP] GO:0042391 |
None
|
ADORA1, BCL2, CACNA1C, GPER1, GRIA2, GRIA4, GRIK5, GRM5, KDR, SRC |
3.29161 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, EGFR, ERBB2, GPER1, IGF1R, KDR, MET, MMP9, PPARG, SRC |
3.29161 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
ADRB1, AR, AURKB, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, GPER1, HSP90AA1, HSP90AB1, IGF1R, MET, NR3C1, PGR, PPARA, PPARG, RORC, SRC |
3.29161 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ALOX15, AR, BCL2, CDC25B, EGFR, ERBB2, FLT3, GPER1, GRM1, GRM5, HSP90AB1, KDR, MMP9, PTPN1, SRC, XDH |
3.27091 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD17B1, HSD17B2 |
3.27047 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC |
3.25806 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ALOX15, AR, EGFR, ERBB2, FLT3, GPER1, GRM1, IGF1R, KDR, PTPN1, SRC, XDH |
3.23636 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, AR, AXL, BCL2, CDC25B, CYP19A1, CYP1A1, EGFR, ESR1, ESRRB, HSD17B2, HSP90AB1, MMP2, MMP9, PGR, PPARG, SRC |
3.23411 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, ALOX15, AR, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPER1, GRM3, GRM8, HCAR2, HSP90AB1, IGF1R, KDR, MET, MMP9, NR3C1, PGR, PIM1, PPARA, PPARG, PTPN1, RORC, SRC, XDH |
3.19321 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
AR, AURKB, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, GPER1, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, NR3C1, PGR, PPARA, PPARG, RORC, SRC |
3.18163 |
[BP] GO:0035265 |
organ growth
|
AR, BCL2, CYP19A1, ESR1 |
3.15982 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, EGFR, MMP9, SRC |
3.15329 |
[BP] GO:0001503 |
ossification
|
ALOX15, ALPL, BCL2, EGFR, MMP2, MMP9 |
3.14328 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, HSP90AB1, RORC |
3.14328 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRB1, AR, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, FABP4, FLT3, GPER1, GRM1, GRM3, GRM5, HSP90AA1, HSP90AB1, IGF1R, MET, MMP9, PIM1, PPARA, PPARG, PTPN1, SRC, XDH |
3.12951 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ALOX15, AR, BCL2, CDC25B, EGFR, ERBB2, ESR1, FLT3, GPER1, GRM1, GRM5, HSP90AB1, KDR, MMP9, PPARG, PTPN1, SRC, XDH |
3.12166 |
[BP] GO:2001225 |
regulation of chloride transport
|
CA2, CA7, GRM5 |
3.09473 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.09473 |
[BP] GO:0009987 |
cellular process
|
ABCG2, ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, PPARG, PTPN1, RORC, SLC1A1, SRC, TYR, XDH |
3.0609 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, EGFR, GPER1, GRIK5, HSP90AA1, HSP90AB1, SLC1A1 |
3.05745 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ALOX15, AXL, BCL2, CA2, CA7, CACNA1C, CYP19A1, EGFR, ERBB2, GPER1, GRIK5, GRM5, HCAR2, HSP90AB1, MMP9, PPARA, PPARG, PTPN1, SRC |
3.04923 |
[BP] GO:0007187 |
None
|
ADORA1, ADRB1, GPER1, GRM1, GRM3, GRM5, GRM8 |
3.03675 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, EGFR, FABP3, FLT3, GPER1, GRM5, HSP90AB1, IGF1R, MMP2, PPARA, PPARG, SRC, TYR |
3.01009 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, ADRB1, AURKB, BCL2, CDC25B, EGFR, ERBB2, ESR1, FLT3, GPER1, GRM1, GRM5, HSP90AA1, HSP90AB1, PPARG, PTPN1, SRC, XDH |
2.99927 |
[BP] GO:0060736 |
prostate gland growth
|
AR, CYP19A1, ESR1 |
2.98096 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, AURKB, CDC25B, EGFR, ERBB2, FABP4, FLT3, GRM1, GRM5, HSP90AA1, HSP90AB1, IGF1R, PPARG, PTPN1, SRC |
2.98096 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, EGFR, ERBB2, GPER1, IGF1R, KDR, MET, MMP9, PPARG, SRC |
2.97105 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, EGFR, GPER1, IGF1R, KDR, MET, MMP9, PPARG, SRC |
2.95456 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, GPER1, MMP2, MMP9, PPARG |
2.8999 |
[BP] GO:0050801 |
ion homeostasis
|
ABCG2, BCL2, CA12, CA2, CA7, CACNA1C, EGFR, ESR1, FABP3, GPER1, GRM1, GRM5 |
2.8784 |
[BP] GO:0007193 |
None
|
ADORA1, GRM1, GRM3, GRM5, GRM8 |
2.87408 |
[BP] GO:0031100 |
animal organ regeneration
|
AXL, CSNK2A1, EGFR, FLT3, PPARG |
2.87408 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, ERBB2, FLT3, HSP90AA1, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
2.85234 |
[BP] GO:0060078 |
None
|
ADORA1, GRIA2, GRIA4, GRIK5, GRM5 |
2.85033 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ALOX15, AR, BCL2, CDC25B, EGFR, ERBB2, FABP4, FLT3, GPER1, GRM1, GRM5, HSP90AA1, HSP90AB1, IGF1R, KDR, MMP9, PTPN1, SRC, XDH |
2.84033 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, AR, AURKB, BCL2, CSNK2A1, EGFR, ESR1, ESR2, ESRRA, FABP4, GPER1, GRM3, GRM8, HCAR2, HSP90AB1, IGF1R, KDR, MET, MMP9, NR3C1, PGR, PPARA, PPARG, PTPN1, RORC, SRC, XDH |
2.81094 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.81094 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, AURKB, CDC25B, EGFR, ERBB2, FLT3, GRM1, GRM5, HSP90AA1, HSP90AB1, PTPN1, SRC |
2.79848 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
AR, BCL2, CA2, CA9, EGFR, ESR1, MET, SRC |
2.79625 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, EGFR, HSP90AB1, KDR, NR3C1, SRC |
2.79625 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.78567 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ALOX15, AR, BCL2, CYP19A1, EGFR, ERBB2, ESR1, ESR2, GPER1, IGF1R, MET, MMP9, PPARA, PPARG, PTPN1, SRC, XDH |
2.78359 |
[BP] GO:0031099 |
regeneration
|
AXL, BCL2, CSNK2A1, EGFR, FLT3, PPARG |
2.78359 |
[BP] GO:0038128 |
None
|
EGFR, ERBB2, HSP90AA1, SRC |
2.78274 |
[BP] GO:0043393 |
regulation of protein binding
|
AURKB, BCL2, HSP90AB1, MET, MMP9, PPARA, SRC |
2.77745 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CSNK2A1, EGFR, ERBB2, FLT3, HSP90AA1, IGF1R, KDR, MET, PIM1, SRC |
2.76987 |
[BP] GO:0033273 |
response to vitamin
|
ALPL, CYP1A1, EGFR, PPARG, TYR |
2.75179 |
[BP] GO:0023052 |
None
|
ADORA1, ADRB1, AR, CACNA1C, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, PGR, SLC1A1 |
2.74061 |
[BP] GO:0032787 |
None
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PPARA, PPARG |
2.73522 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, EGFR, FABP3, FLT3, GPER1, GRM5, HSP90AB1, IGF1R, MMP2, PPARA, PPARG, SRC, TYR |
2.72528 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, EGFR, ERBB2, GPER1, MET, SRC, XDH |
2.71164 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.70839 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, ADRB1, ALOX15, AR, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GPER1, GRM1, GRM3, GRM5, GRM8, HCAR2, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, PPARG, PTPN1, RORC, SRC, XDH |
2.70245 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, FABP4, FUT7, HSP90AA1, MMP1, MMP2, MMP9, SRC, XDH |
2.66426 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
2.60345 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRB1, AR, AXL, BCL2, CA2, CACNA1C, CYP1B1, EGFR, ERBB2, ESR1, ESRRA, ESRRB, GPER1, GRM1, HCAR2, HSP90AB1, KDR, MET, MMP9, PIM1, PPARG, SLC1A1, SRC, XDH |
2.57332 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CYP1A1, CYP1B1, HSP90AA1, KDR, SRC |
2.56381 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.53986 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ADRB1, ALOX15, AR, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GPER1, GRM1, GRM3, GRM5, GRM8, HCAR2, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, PPARG, PTPN1, RORC, SRC, XDH |
2.5364 |
[BP] GO:1905475 |
None
|
AR, BCL2, CSNK2A1, EGFR, ERBB2, GPER1 |
2.53636 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPER1, GRM3, GRM8, HSP90AB1, IGF1R, KDR, MET, MMP9, NR3C1, PIM1, PPARA, PPARG, PTPN1, RORC, SRC, XDH |
2.50979 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, CDC25B, EGFR, ERBB2, FLT3, GRM1, GRM5, HSP90AB1, PTPN1, SRC |
2.5049 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, KDR, SRC |
2.50225 |
[BP] GO:0007267 |
None
|
ADORA1, ADRB1, AR, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, PGR, SLC1A1 |
2.49997 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, AR, BCL2, EGFR, ERBB2, ESR1, ESR2, GPER1, IGF1R, MET, MMP9, PPARG, PTPN1, SRC, XDH |
2.47595 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, BCL2, CA2, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
2.47199 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, AR, BCL2, EGFR, ERBB2, ESR1, ESR2, GPER1, IGF1R, MET, MMP9, PPARG, PTPN1, SRC, XDH |
2.46307 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, EGFR, FABP3, HSD17B2, KDR, MMP2, PPARG, SRC |
2.44663 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
ABCG2, BCL2, CA12, CA2, CA7, CACNA1C, EGFR, ESR1, GPER1, GRM1, GRM5 |
2.41216 |
[BP] GO:0099566 |
None
|
GRM1, GRM5 |
2.41216 |
[BP] GO:0060748 |
None
|
AR, PGR |
2.41216 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.41216 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.41216 |
[BP] GO:1901184 |
None
|
ADORA1, EGFR, ERBB2, GPER1, MMP9 |
2.41204 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, AURKB, CSNK2A1, CYP1B1, ESR1, FABP4, GRM3, IGF1R, MET, MMP9, PIM1, PPARA, PPARG, PTPN1, SRC |
2.38612 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.35319 |
[BP] GO:0010676 |
None
|
ESRRB, GPER1, PPARA, SRC |
2.35259 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.34521 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRB1, AKR1B1, ALOX15, AR, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, ESRRA, FABP4, FLT3, GPER1, GRM1, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP2, MMP9, PPARA, PPARG, PTPN1, SRC, XDH |
2.34521 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
BCL2, CYP1B1, EGFR, HSP90AA1, HSP90AB1, XDH |
2.33313 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, CDC25B, EGFR, ERBB2, FLT3, GRM1, GRM5, HSP90AB1, PTPN1, SRC |
2.31056 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, EGFR, ERBB2, FLT3, GRM1, IGF1R, PTPN1, SRC |
2.31056 |
[BP] GO:2000278 |
regulation of DNA biosynthetic process
|
AURKB, HSP90AA1, HSP90AB1, PPARG, SRC |
2.31056 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, GPER1, HSP90AB1, MMP2, PPARA, PPARG, PTPN1, SRC |
2.30507 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
2.30169 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, CDC25B, EGFR, ERBB2, FABP4, FLT3, GRM1, GRM5, HSP90AB1, IGF1R, PTPN1, SRC |
2.29765 |
[BP] GO:0051098 |
regulation of binding
|
AURKB, BCL2, HSP90AB1, MET, MMP9, PPARA, PPARG, SRC |
2.29552 |
[BP] GO:0032870 |
cellular response to hormone stimulus
|
AR, EGFR, ESR1, FLT3, GPER1, NR3C1, PPARG, SRC |
2.29552 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, ADRB1, ALOX15, AR, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GPER1, GRM1, GRM3, GRM5, GRM8, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, PPARG, PTPN1, RORC, SRC, XDH |
2.29513 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.2838 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
2.26759 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, ADRB1, ALOX15, AR, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GPER1, GRM1, GRM3, GRM5, GRM8, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, PPARG, PTPN1, RORC, SRC, XDH |
2.25304 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, FABP3, GPER1, GRM5, IGF1R, PPARA, PPARG, SRC |
2.25304 |
[BP] GO:0071902 |
positive regulation of protein serine/threonine kinase activity
|
ADORA1, EGFR, ERBB2, FLT3, GRM1, HSP90AB1, PTPN1, SRC |
2.23772 |
[BP] GO:0002521 |
leukocyte differentiation
|
AXL, BCL2, FLT3, FUT7, MMP9, PPARG, RORC |
2.21766 |
[BP] GO:0048729 |
tissue morphogenesis
|
AR, BCL2, CA2, CA9, EGFR, ESR1, MET, SRC |
2.20645 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADORA1, BCL2, EGFR, HCAR2, HSP90AB1, MET, PPARA |
2.19989 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, EGFR, ERBB2, FLT3, GRM1, PTPN1, SRC |
2.19107 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.18631 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, ALOX15, AXL, BCL2, CA2, CYP19A1, ERBB2, ESR1, ESRRA, GPER1, HCAR2, HSP90AA1, HSP90AB1, MMP2, PPARG, PTPN1, SRC |
2.18478 |
[BP] GO:1905323 |
None
|
HSP90AA1, HSP90AB1 |
2.17397 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.17397 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.17397 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRB1, AR, AXL, BCL2, CA2, CYP1B1, EGFR, ESRRB, GPER1, HCAR2, KDR, MET, MMP9, PIM1, PPARG, SLC1A1, SRC |
2.17397 |
[BP] GO:0071384 |
None
|
EGFR, FLT3, GPER1, NR3C1 |
2.16586 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CYP19A1, GPER1, PPARA, PPARG |
2.16586 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
2.14749 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.14406 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, AXL, BCL2, CA2, CYP19A1, EGFR, ERBB2, GPER1, HCAR2, HSP90AB1, PPARG, SRC |
2.12951 |
[BP] GO:0006082 |
organic acid metabolic process
|
ABCG2, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PIM1, PPARA, PPARG, TYR |
2.12191 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ALOX15, EGFR, ERBB2, GPER1, KDR, PTPN1, SRC |
2.11339 |
[BP] GO:0035902 |
response to immobilization stress
|
CYP1A1, CYP1A2, PPARG |
2.09567 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.09567 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRB1, AKR1B1, ALOX15, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, FLT3, GPER1, GRM1, HSP90AB1, IGF1R, KDR, MET, MMP9, PPARG, PTPN1, SRC, XDH |
2.08821 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, CA2, CA7, EGFR, GPER1 |
2.07685 |
[BP] GO:0010675 |
None
|
ESRRB, GPER1, PPARA, RORC, SRC |
2.07685 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, HSP90AA1, HSP90AB1, SRC |
2.07346 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC |
2.07168 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, CDC25B, EGFR, ERBB2, FABP4, FLT3, GRM1, GRM5, HSP90AB1, IGF1R, PTPN1, SRC |
2.05462 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, PPARG, SRC |
2.04877 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, AR, AURKB, AXL, BCL2, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, PPARG, PTPN1, RORC, SRC, TYR, XDH |
2.03493 |
[BP] GO:0032355 |
response to estradiol
|
CYP1A2, EGFR, ESR1, ESRRA, GPER1 |
2.03493 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.02122 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PIM1, PPARA, PPARG, TYR |
2.0152 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD17B1, HSD17B2 |
2.00828 |
[BP] GO:0035235 |
None
|
GRIA2, GRIA4, GRIK5 |
2.00828 |
[CC] GO:0098590 |
plasma membrane region
|
ABCG2, ADORA1, CA2, CA4, CA9, EGFR, ERBB2, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSP90AA1, HSP90AB1, MET, SLC1A1, SRC |
6.32249 |
[CC] GO:0042734 |
None
|
GPER1, GRIK5, GRM1, GRM3, GRM5, GRM8 |
4.46641 |
[CC] GO:0005886 |
plasma membrane
|
ABCG2, ACHE, ADORA1, ADORA3, ADRB1, ALOX15, ALPL, AR, AXL, CA12, CA14, CA2, CA4, CA9, CACNA1C, CSNK2A1, EGFR, ERBB2, ESR1, FLT3, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSP90AA1, IGF1R, KDR, MET, MMP2, PIM1, PTPN1, SLC1A1, SRC |
4.20616 |
[CC] GO:0016020 |
membrane
|
ABCG2, ACHE, ADORA1, ADORA3, ADRB1, ALOX15, ALOX5, ALPL, AR, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, ERBB2, ESR1, FLT3, FUT7, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD11B1, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP2, NR3C2, PGR, PIM1, PTPN1, SLC1A1, SRC, TYR |
4.05141 |
[CC] GO:0043235 |
receptor complex
|
ABCG2, EGFR, ERBB2, GRIA2, GRIA4, GRIK5, GRM1, HSP90AB1, IGF1R, NR3C2 |
4.00615 |
[CC] GO:0044459 |
plasma membrane part
|
ABCG2, ADORA1, ADORA3, ADRB1, ALOX15, AXL, CA2, CA4, CA9, CACNA1C, EGFR, ERBB2, FLT3, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, SLC1A1, SRC |
3.99803 |
[CC] GO:0014069 |
None
|
ADORA1, CACNA1C, GPER1, GRIK5, GRM1, GRM3, GRM5, SRC |
3.73857 |
[CC] GO:0099572 |
None
|
ADORA1, CACNA1C, GPER1, GRIK5, GRM1, GRM3, GRM5, SRC |
3.73857 |
[CC] GO:0044425 |
membrane part
|
ABCG2, ACHE, ADORA1, ADORA3, ADRB1, ALOX15, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, ERBB2, ESR1, FLT3, FUT7, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD11B1, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, NR3C2, PTPN1, SLC1A1, SRC, TYR |
3.44171 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, CA2, CA4, CA9, EGFR, ERBB2, HSP90AB1 |
2.99927 |
[CC] GO:0097060 |
None
|
GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
2.75535 |
[CC] GO:0044456 |
None
|
ACHE, ADORA1, CACNA1C, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, SRC |
2.75535 |
[CC] GO:0044444 |
cytoplasmic part
|
ABCG2, ACHE, ADORA1, ADRB1, AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, AR, AURKB, BCL2, CA1, CA2, CA4, CA5A, CA5B, CA7, CACNA1C, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, ERBB2, ESR1, ESR2, FABP3, FABP4, FLT3, FUT7, GPER1, GRIA2, GRIA4, GRIK5, HSD11B1, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, KDR, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARG, PTPN1, SRC, TYR, XDH |
2.59708 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, GPER1, GRIA2, HSD11B1, HSD17B2, NR3C2 |
2.29756 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, ALOX5, AOX1, AR, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, PPARG, PTPN1, RORC, TYR, XDH |
20.0152 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
16.7506 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, NR3C1, NR3C2, PGR, PPARA, PPARG, RORC |
13.3377 |
[MF] GO:0005496 |
steroid binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, HSD17B1, NR3C1, NR3C2, PGR, RORC, SHBG |
11.3638 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRB1, AR, AXL, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, NR3C1, NR3C2, PGR, PPARA, PPARG, RORC |
11.0799 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PGR, PPARA, PPARG, RORC |
11.0123 |
[MF] GO:0004879 |
nuclear receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PGR, PPARA, PPARG, RORC |
11.0123 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, NR3C1, NR3C2, PGR, PPARA, PPARG, PTPN1, RORC |
11.0077 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.5951 |
[MF] GO:0043167 |
ion binding
|
ABCG2, ACHE, ALOX15, ALOX5, ALPL, AOX1, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, HSD17B1, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, PPARG, PTPN1, RORC, SLC1A1, SRC, TYR, XDH |
10.3436 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRB1, AR, AXL, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, NR3C1, NR3C2, PGR, PPARA, PPARG, RORC |
10.1019 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRB1, AR, AXL, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, NR3C1, NR3C2, PGR, PPARA, PPARG, RORC |
9.79223 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
9.4132 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRB1, AR, AXL, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, NR3C1, NR3C2, PGR, PPARA, PPARG, RORC |
9.16807 |
[MF] GO:0008066 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
8.1058 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, AR, AXL, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPER1, HSD17B1, NR3C1, NR3C2, PGR, PPARA, PPARG, RORC, SHBG |
7.13769 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALOX5, ALPL, AOX1, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, PPARG, PTPN1, RORC, SLC1A1, TYR, XDH |
6.68522 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
6.43345 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALOX5, ALPL, AOX1, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, PPARG, PTPN1, RORC, SLC1A1, TYR, XDH |
6.41468 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, XDH |
6.41305 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, EGFR, GPER1, HSD17B1, IGF1R, NR3C1, SHBG |
6.13439 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
5.9273 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET |
5.73443 |
[MF] GO:0030235 |
nitric-oxide synthase regulator activity
|
EGFR, ESR1, HSP90AA1, HSP90AB1 |
5.56004 |
[MF] GO:0003824 |
catalytic activity
|
ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, ERBB2, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HSP90AA1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PTPN1, SRC, TYR, XDH |
5.38039 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD11B1, HSD17B1, HSD17B2, TYR, XDH |
5.15666 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET |
5.09859 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
5.09859 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, ERBB2, FLT3, HSP90AA1, IGF1R, KDR, MET, SRC |
4.96231 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRB1, AXL, EGFR, ERBB2, FLT3, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, PPARG |
4.83071 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRB1, AXL, EGFR, ERBB2, FLT3, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, KDR, MET, PPARG |
4.83071 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
4.66611 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2, GPER1 |
3.99803 |
[MF] GO:0008144 |
drug binding
|
ABCG2, ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, EGFR, ERBB2, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, PIM1, PPARA, PPARG, SRC |
3.9965 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, SRC |
3.90437 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
3.82652 |
[MF] GO:0042802 |
identical protein binding
|
ABCG2, ACHE, AOX1, BCL2, CSNK2A1, EGFR, ERBB2, ESR1, ESR2, FLT3, GRIK5, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP9, PGR, PPARG, TYR, XDH |
3.81453 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD11B1, HSD17B1, HSD17B2, XDH |
3.74551 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, SRC |
3.71791 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
3.44171 |
[MF] GO:0019902 |
phosphatase binding
|
BCL2, EGFR, ERBB2, MET, PPARA, PPARG, PTPN1 |
3.29161 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, ERBB2, KDR |
3.22303 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, CSNK2A1, EGFR, ESRRB, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MMP9, PIM1, PPARA, PTPN1, SRC |
3.09542 |
[MF] GO:0019903 |
protein phosphatase binding
|
BCL2, EGFR, ERBB2, MET, PPARG, PTPN1 |
3.07046 |
[MF] GO:0019899 |
enzyme binding
|
ADRB1, AR, AURKB, BCL2, CDC25B, CYP1A1, CYP1A2, CYP2A6, EGFR, ERBB2, ESR1, ESR2, ESRRB, GRM5, HSP90AA1, HSP90AB1, MET, NR3C1, PGR, PPARA, PPARG, PTPN1, SRC |
3.03331 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6 |
2.98096 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, HSP90AA1, IGF1R, KDR, MET, PIM1, SRC |
2.97511 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, EGFR, ESRRB, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC |
2.84532 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.81094 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.81094 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD17B1, SRC, XDH |
2.70981 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.59937 |
[MF] GO:0046983 |
protein dimerization activity
|
ABCG2, ACHE, ADORA1, ADRB1, AOX1, AR, AXL, BCL2, EGFR, ERBB2, FLT3, HSP90AA1, HSP90AB1, PPARG, TYR, XDH |
2.57199 |
[MF] GO:0099583 |
None
|
GRM1, GRM5 |
2.41216 |
[MF] GO:0004970 |
None
|
GRIA2, GRIA4, GRIK5 |
2.34521 |
[MF] GO:0005234 |
None
|
GRIA2, GRIA4, GRIK5 |
2.34521 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, HSP90AA1, IGF1R, KDR, MET, PIM1, SRC |
2.31307 |
[MF] GO:0031072 |
heat shock protein binding
|
ADORA1, CSNK2A1, HSP90AB1, KDR, NR3C1 |
2.31056 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.26759 |
[MF] GO:0030594 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM5 |
2.25304 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.17397 |
[MF] GO:0004971 |
None
|
GRIA2, GRIA4 |
2.17397 |
[MF] GO:0005497 |
None
|
AR, SHBG |
2.17397 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HSD11B1, HSD17B1, HSD17B2 |
2.10409 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, HSP90AA1, IGF1R, KDR, MET, PIM1, SRC |
2.02197 |